We are monitoring the impact of COVID-19 on U.S. DNA Sequencing Market Get in touch with us for detailed analysis Know More
Pulished Date May, 2021
ID: 11551
Share on
Share on

U.S. DNA Sequencing Market Research Report – Segmented By Product & Services, Technology, Workflow, Application, End User and Country – Industry Size, Share, Trends, COVID-19 Impact and Growth Forecast (2021 to 2026)

Pulished: May, 2021
ID: 11551
Pages: 90

U.S. DNA Sequencing Market Size (2021 to 2026)

The size of the DNA sequencing market in the United States is estimated to grow at 11.92% CAGR between 2021 to 2026.

DNA sequencing is used in various applications, including biomarkers, personalized medicine, oncology research, and forensics. Researchers have used DNA sequencing to classify attractive characteristics, which has resulted in more robust and profitable livestock and crops. The growing use and application of DNA sequencing are expected to drive the U.S. DNA sequencing market. Cost-effectiveness and current conversion parameters to generate efficient outcomes in genome medicines are likely to favor the market growth. The growing cancer occurrence has a significant impact on the DNA sequencing market. Besides that, the increasing use of genome mapping systems in the U.S. uplifts the market growth. The sector has expanded rapidly in recent years in the United States due to many technology leaders adopting cutting-edge NGS innovations. The cloud-based hub simplifies genomics data collection, management, and research.

Similarly, policies and technologies in developing markets are supposed to fuel market growth. New market players have been attracted to the United States DNA sequencing market, fuelling the region's market growth. The government's growing investment and funding for developing the healthcare infrastructure and favorable government regulatory policies influence market growth. Through the widespread use of Next-generation Sequencing (NGS) and Whole-genome Sequencing (WGS), a wide variety of genes can be examined in a single diagnostic tool simultaneously, expanding the usefulness of DNA sequencing in clinical diagnosis applications.

Major concerns about DNA sequencing precision and standardization, as well as ethical and legal constraints, are likely to slow down the U.S. DNA sequencing market expansion.

Impact on COVID-19 on the U.S. DNA sequencing market:

During the pandemic period 2020, SARS-COV-2 has had a positive effect on the U.S. DNA Sequencing market. COVID-19 was identified in 2019 in Wuhan, China. The pandemic emerged as a localized pandemic and has since spread on a global scale. The covid-19 pandemic has completely transformed the healthcare sector. Pharmaceutical and biopharmaceutical firms, both private and public, have increased their research and funding efforts to produce an effective vaccine for the covid-19. The coronavirus genome monitoring sequence aids in tracking the infection and how it spreads across populations and affects the human genome. This data will be used to provide a cure for the infection. Researchers are using the virus genome data to track the sources of COVID-19 infection and the initiation of community spread.

This research report on the U.S. DNA sequencing market has been segmented & sub-segmented into the following categories.

By Product & Services:

  • Consumables
  • Instruments
  • Services

By Technology:

  • Sanger Sequencing
  • Next-Generation Sequencing
  • Whole Genome Sequencing (WGS)
  • Whole Exome Sequencing (WES)
  • Targeted Sequencing & Resequencing
  • Third Generation DNA Sequencing  
  • Single-Molecule Real-Time Sequencing (SMRT)
  • Nanopore Sequencing

By Workflow:

  • Pre-sequencing
  • Sequencing
  • Data Analysis

By Application:

  • Oncology
  • Reproductive Health
  • Clinical Investigation
  • Agri genomics & Forensics
  • HLA Typing/Immune System Monitoring
  • Metagenomics, Epidemiology & Drug Development
  • Consumer Genomics
  • Others

By End-use:

  • Academic Research
  • Clinical Research
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Other Users

By Country:

  • The United States

Regionally, the United States DNA sequencing market is expected to account for the most significant share in the global DNA sequencing market during the forecast period. The market growth is attributed to the factors such as constant technological advancements in sequencing methods, evolving the fields of bioinformatics, and growing applications of next-generation sequencing. Also, the United States is predicted to have the largest share in the North American region, owing to industry leaders and increased knowledge of next-generation sequencing technologies. The United States is majorly contributing to the growth of the DNA sequencing market in North America. Over the last few years, the country has witnessed a rise in the incidences of cancer cases. In terms of the revenue share, the U.S market dominates this region. Supportive government initiatives are propelling this country's growth. In the recent past, COVID-19 has significantly increased the market growth due to the rising demand for DNA sequencing.  Many Pharmaceutical and biopharmaceutical firms in the United States have increased their research and funding efforts to produce an effective vaccine for the covid-19. As a result of the growing DNA sequencing-based research and development activities in developing diagnostic tools or successful COVID-19 therapeutics, it is expected that the market will continue to expand at a significant pace during the forecast period.


Notable companies operating in the U.S. DNA sequencing market profiled in this report are Agilent Technologies, Inc., Abbott Laboratories, Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche Ltd, Illumina, Inc., LI-COR Biosciences, Inc., Pacific Biosciences of California, Inc., SIEMENS AG, PerkinElmer Inc., and Thermo Fisher Scientific, Inc.

    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year, and Forecast Periods
    4. General Study Assumptions
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Report Overview
    1. Executive Summary
    2. Key Inferences
  4. Market Dynamics
    1. Impact Analysis
      1. Drivers
      2. Restraints
      3. Opportunities       
    2. Regulatory Environment
    3. Technology Timeline & Recent Trends
  5. Competitor Benchmarking Analysis
    1. Key Player Benchmarking                    
      1. Market share analysis      
      2. Products/Service
      3. Regional Presence               
    2. Mergers & Acquisition Landscape                     
    3. Joint Ventures & Collaborations
    1. Products and Services
      1. Consumables
      2. Instruments
      3. Services
      4. Y-o-Y Growth Analysis, By Products and Services
      5. Market Attractiveness Analysis, By Products and Services
      6. Market Share Analysis, By Products and Services
    2. By Technology
      1. Sanger Sequencing
      2. Next-Generation Sequencing
      3. Whole Genome Sequencing (WGS)
      4. Whole Exome Sequencing (WES)
      5. Targeted Sequencing & Resequencing
      6. Third Generation DNA Sequencing  
      7. Single-Molecule Real-Time Sequencing (SMRT)
      8. Nanopore Sequencing
      9. Y-o-Y Growth Analysis, By Technology
      10. Market Attractiveness Analysis, By Technology
      11. Market Share Analysis, By Technology
    3. By Workflow
      1. Pre-sequencing
      2. Sequencing
      3. Data Analysis
      4. Y-o-Y Growth Analysis, By Workflow
      5. Market Attractiveness Analysis, By Workflow
      6. Market Share Analysis, By Workflow
    4. By Application
      1. Oncology
      2. Reproductive Health
      3. Clinical Investigation
      4. Agri genomics & Forensics
      5. HLA Typing/Immune System Monitoring
      6. Metagenomics, Epidemiology & Drug Development
      7. Consumer Genomics
      8. Others
      9. Y-o-Y Growth Analysis, By Application
      10. Market Attractiveness Analysis, By Application
      11. Market Share Analysis, By Application
    5. By End-User
      1. Academic Research
      2. Clinical Research
      3. Hospitals & Clinics
      4. Pharmaceutical & Biotechnology Companies
      5. Other Users
      6. Y-o-Y Growth Analysis, By End User
      7. Market Attractiveness Analysis, By End User
      8. Market Share Analysis, By End User
    1. Introduction
      1. Regional Trends
      2. Impact Analysis
      3. Y-o-Y Growth Analysis
      4. Market Attractiveness Analysis
      5. Market Share Analysis
    2. United States
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. The threat of New Entrants
      4. The threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
    1. Abbott Laboratories
      1. Overview
      2. Products
      3. Financials (subjected to availability based on company type)
      4. Recent Developments
      5. SWOT analysis
      6. Analyst View
    2. Agilent Technologies, Inc.
    3. Danaher Corporation (Beckman Coulter, Inc.)
    4. F. Hoffmann-La Roche Ltd
    5. Illumina, Inc.
    6. LI-COR Biosciences, Inc.
    7.  Pacific Biosciences of California, Inc.
    8.  SIEMENS AG
    9. PerkinElmer Inc.,
    10. Thermo Fisher Scientific, Inc.
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations, and Joint Ventures
    4. New Product Launches
    1. List of Tables
    2. List of Figures
  • Country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and identify the regions that are still untapped.
  • The segment-level analysis in terms of products and services, workflow, application, and end-user along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market, including broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the microenvironment factors that determine an Industry's overall profitability, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.
  • A comprehensive list of key market players and their proDNA Sequencing Marketduct portfolio, current strategic interests, key financial information, legal issues, SWOT analysis, and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field, new product launches, comparative financial studies, and recent developments in the market by the major companies.
  • An executive summary abridges the entire report so that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions.
  • Expertly devised analyst overview and investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. United States DNA Sequencing Market, By Product & Services, From 2021 to 2026 (USD Billion)
  2. United States DNA Sequencing Market, By Technology, From 2021 to 2026 (USD Billion)
  3. United States DNA Sequencing Market, By Workflow, From 2021 to 2026 (USD Billion)
  4. United States DNA Sequencing Market, By Application, From 2021 to 2026 (USD Billion)
  5. United States DNA Sequencing Market, By End-use, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports


$ 1234 3335

Click for Request Sample